Fruquin 5mg Capsule (Fruquintinib) – Long Product Description

Fruquin 5mg Capsule (Fruquintinib) is a prescription targeted anti-cancer medicine manufactured by Everest Pharmaceuticals Ltd. It contains Fruquintinib 5mg, a highly selective vascular endothelial growth factor receptor (VEGFR) inhibitor used for the treatment of metastatic colorectal cancer (mCRC) in adult patients who have previously received standard cancer therapies. By blocking the formation of new blood vessels that supply nutrients and oxygen to tumors, Fruquin helps slow tumor growth and disease progression.

Each pack of Fruquin 5mg Capsule contains 21 capsules, providing a complete treatment cycle commonly prescribed as 21 consecutive days of treatment followed by 7 days off, or as directed by an oncologist. Fruquintinib has become an important targeted therapy option for patients with advanced colorectal cancer who require additional treatment after conventional chemotherapy.

How Fruquin 5mg Capsule Works

Fruquintinib is a highly selective VEGFR-1, VEGFR-2, and VEGFR-3 inhibitor. Cancer cells depend on the development of new blood vessels (angiogenesis) to grow and spread. Fruquin blocks VEGFR signaling, preventing the formation of these blood vessels and reducing the supply of oxygen and nutrients to tumors.

By inhibiting tumor angiogenesis, Fruquin helps slow cancer progression and may improve survival outcomes in patients with metastatic colorectal cancer.

Uses of Fruquin 5mg Capsule

Fruquin 5mg Capsule is indicated for:

• Treatment of metastatic colorectal cancer (mCRC) in adults.
• Patients whose disease has progressed following standard chemotherapy and other approved treatments.
• Advanced colorectal cancer requiring targeted anti-angiogenic therapy.
• Treatment under the supervision of an experienced oncologist.

The treatment plan is individualized according to the patient’s condition, previous therapies, and response to treatment.

Benefits of Fruquin 5mg Capsule

Fruquin offers several important clinical benefits, including:

• Helps slow the progression of metastatic colorectal cancer.
• Inhibits tumor blood vessel formation (angiogenesis).
• Oral capsule formulation for convenient outpatient treatment.
• Highly selective VEGFR inhibitor with targeted action.
• May improve overall survival and progression-free survival in eligible patients.
• Manufactured by Everest Pharmaceuticals Ltd., a trusted pharmaceutical company.

Dosage and Administration

Fruquin 5mg Capsule should be taken exactly as prescribed by an oncologist. The commonly recommended regimen is one capsule once daily for 21 consecutive days, followed by 7 days without treatment, completing a 28-day treatment cycle.

The capsules should be swallowed whole with water and may be taken with or without food. Patients should not change the dose or discontinue therapy without consulting their healthcare provider.

Regular monitoring of blood pressure, liver function, kidney function, complete blood counts, and urine protein levels is recommended throughout treatment.

Possible Side Effects

Like all targeted cancer medicines, Fruquin may cause side effects, although not everyone experiences them.

Common side effects include:

• High blood pressure
• Fatigue
• Diarrhea
• Loss of appetite
• Nausea
• Hoarseness
• Hand-foot syndrome (palmar-plantar erythrodysesthesia)
• Protein in the urine
• Mouth sores
• Weight loss

Serious side effects may include:

• Severe hypertension
• Gastrointestinal perforation
• Serious bleeding
• Blood clots
• Liver dysfunction
• Delayed wound healing
• Severe infections
• Allergic reactions

Patients should seek immediate medical attention if they experience severe abdominal pain, significant bleeding, chest pain, sudden swelling, severe headache, or difficulty breathing.

Precautions and Warnings

Before taking Fruquin 5mg Capsule, inform your healthcare provider if you have:

• High blood pressure
• Heart disease
• Liver disease
• Kidney disease
• Bleeding disorders
• Recent surgery or planned surgery
• Pregnancy or plans to become pregnant
• Breastfeeding

Blood pressure should be well controlled before starting treatment, and regular monitoring is recommended during therapy.

Women and men of reproductive potential should use effective contraception throughout treatment and for the recommended period after the last dose.

Storage Information

Store Fruquin 5mg Capsules at room temperature below 30°C, protected from heat, moisture, and direct sunlight. Keep the capsules in their original packaging and out of the reach of children.

Why Buy Fruquin 5mg Capsule from MedicineWalyDost?

At MedicineWalyDost, we provide genuine targeted oncology medicines sourced from trusted pharmaceutical manufacturers. Fruquin 5mg Capsule by Everest Pharmaceuticals is available with reliable nationwide delivery across Pakistan for oncology hospitals, clinics, and eligible patients requiring advanced colorectal cancer treatment.

When you order from MedicineWalyDost, you receive:

• Genuine oncology medicines
• Competitive prices
• Nationwide delivery across Pakistan
• Secure packaging
• Professional customer support
• Assistance with medicine availability and ordering

Note: A valid prescription from a qualified oncologist is required before purchasing Fruquin 5mg Capsule.

---

Frequently Asked Questions (FAQs)

What is Fruquin 5mg Capsule used for?

Fruquin 5mg Capsule is used to treat metastatic colorectal cancer (mCRC) in adults whose disease has progressed after previous standard treatments.

Who manufactures Fruquin 5mg Capsule?

Fruquin 5mg Capsule is manufactured by Everest Pharmaceuticals Ltd.

What is the pack size?

Each pack contains 21 capsules.

How should Fruquin be taken?

The usual dosage is one capsule once daily for 21 days, followed by 7 days off treatment, or as directed by your oncologist.

Is a prescription required?

Yes. Fruquin 5mg Capsule is a prescription-only targeted cancer medicine and should only be used under the supervision of a qualified oncologist.